(PharmaNewsWire.Com, June 01, 2017 ) Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Head And Neck Cancer - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Head And Neck Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Head and Neck Cancer is cancer that arises in the head or neck region (in the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx). The common symptoms of cancer of the head and neck include persistent pain in the throat, pain or difficulty with swallowing, persistent hoarseness or a change in voice, pain in the ear and bleeding in the mouth or throat. The disease may be controlled by chemotherapy and radiation therapy.
The Head Neck Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Head And Neck Cancer and features dormant and discontinued projects. The guide covers Therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 18, 87, 98, 5, 92, 17 and 3 respectively. Similarly, the Universities portfolio in Phase II, Phase I, IND/CTA Filed, and Preclinical and Discovery stages comprises 11, 6, 1, 15 and 3 molecules, respectively.
Head and Neck Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios enhance decision-making capabilities and help to create effective counter-strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope:
- The pipeline guide provides a snapshot of the global therapeutic landscape of Head And Neck Cancer (Oncology). - The pipeline guide reviews pipeline therapeutics for Head and Neck Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. - The pipeline guide reviews key companies involved in Head And Neck Cancer (Oncology) therapeutics and enlists all their major and minor projects. - The pipeline guide evaluates Head And Neck Cancer (Oncology) therapeutics based on the mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. - The pipeline guide encapsulates all the dormant and discontinued pipeline projects. - The pipeline guide reviews the latest news related to pipeline therapeutics for Head And Neck Cancer (Oncology)
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. - Recognize emerging players with the potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Find and recognize significant and varied types of therapeutics under development for Head And Neck Cancer (Oncology). - Classify potential new clients or partners in the target demographic. - Develop tactical initiatives by understanding the focus areas of leading companies. - Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics. - Formulate corrective measures for pipeline projects by understanding Head And Neck Cancer (Oncology) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents: Table of Contents 2 Introduction 9 Head And Neck Cancer - Overview 10 Head And Neck Cancer - Therapeutics Development 11 Head And Neck Cancer - Therapeutics Assessment 51 Head And Neck Cancer - Companies Involved in Therapeutics Development 75 Head And Neck Cancer - Drug Profiles 167 Head And Neck Cancer - Dormant Projects 1190 Head And Neck Cancer - Discontinued Products 1200 Head And Neck Cancer - Product Development Milestones 1202 Appendix 1211
List of Tables Number of Products under Development for Head And Neck Cancer, H1 2017 46 Number of Products under Development by Companies, H1 2017 48 Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017 49 Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017 50 Number of Products under Development by Companies, H1 2017 (Contd..3), H1 2017 51 Number of Products under Development by Companies, H1 2017 (Contd..4), H1 2017 52 Number of Products under Development by Companies, H1 2017 (Contd..5), H1 2017 53 Number of Products under Development by Companies, H1 2017 (Contd..6), H1 2017 54 Number of Products under Development by Companies, H1 2017 (Contd..7), H1 2017 55 Number of Products under Development by Companies, H1 2017 (Contd..8), H1 2017 56
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
